Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 224

The DOI matches its Crossref record.

Frequent hSNF5/INI1 Germline Mutations in Patients with Rhabdoid Tumor

Open access
Bourdeaut, Franck, Lequin, Delphine, Brugières, Laurence, Reynaud, Stéphanie, Dufour, Christelle, Doz, François, André, Nicolas, Stephan, Jean-Louis, Pérel, Yves, Oberlin, Odile, Orbach, Daniel, Bergeron, Christophe, Rialland, Xavier, Fréneaux, Paul, Ranchere, Dominique, Figarella-Branger, Dominique, Audry, Georges, Puget, Stéphanie, Evans, D. Gareth, Pinas, Joan Carles Ferreres, Capra, Valeria, Mosseri, Véronique, Coupier, Isabelle, Gauthier-Villars, Marion, Pierron, Gaëlle, Delattre, Olivier·2011·Clinical Cancer Research

Abstract

Purpose: Germline hSNF5/INI1 mutations are responsible for hereditary cases of rhabdoid tumors (RT) that constitute the rhabdoid predisposition syndrome (RPS). Our study provides the first precise overview of the prevalence of RPS within a large cohort of RT. Experimental Design: hSNF5/INI1 coding exons were investigated by sequencing and by multiplex ligation-dependent probe amplification. Results: Seventy-four constitutional DNAs from 115 apparently sporadic RT were analyzed from 1999 to 2009. Germline mutations were found in 26 patients (35%). Data from 9 individuals from 5 RPS families (siblings) were also studied. The median age at diagnosis was much lower (6 months) in patients with germline mutation (P < 0.01) than in patients without (18 months). Nevertheless, 7 of 35 patients with germline mutation (20%) developed the disease after 2 years of age. The mutation could be detected in only 1 parent whereas germline blood DNA was wild type in the 20 other parent pairs, therefore indicating the very high proportion of germ-cell mosaicism or of de novo mutations in RPS. The former hypothesis could be clearly documented in 1 case in which prenatal diagnosis was positive in a new pregnancy. Finally, the 2 years' overall survival was 7% in mutated and 29% in wild-type patients, mainly due to the worse outcome of RT in younger patients. Conclusions: Our results show a high proportion of germline mutations in patients with RT that can be found at any age and up to 60% in the youngest patients. Genetic counseling is recommended given the low but actual risk of familial recurrence. Clin Cancer Res; 17(1); 31–8. ©2011 AACR.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1158/1078-0432.ccr-10-1795

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 224

Metadata

Authors
Bourdeaut, F., Lequin, D., Brugières, L., Reynaud, S., Dufour, C., Doz, F., André, N., Stephan, J.-L., Pérel, Y., Oberlin, O., Orbach, D., Bergeron, C., Rialland, X., Fréneaux, P., Ranchere, D., Figarella-Branger, D., Audry, G., Puget, S., Evans, D. G., Pinas, J. C. F., Capra, V., Mosseri, V., Coupier, I., Gauthier-Villars, M., Pierron, G., & Delattre, O.
Venue
Clinical Cancer Research
Published
2011-01-01
Volume
17
Issue
1
Pages
31-38
ISSN
  • 1078-0432 (ISSN-L)
  • 1557-3265
OpenAlex
W2125272664
Cited by
224
References
0
FWCI
5.17
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Frequent hSNF5/INI1 Germline Mutations in Patients with Rhabdoid Tumor. https://app.cochat.ai/papers/10.1158/1078-0432.ccr-10-1795
The paper
Bourdeaut, F., Lequin, D., Brugières, L., Reynaud, S., Dufour, C., Doz, F., André, N., Stephan, J.-L., Pérel, Y., Oberlin, O., Orbach, D., Bergeron, C., Rialland, X., Fréneaux, P., Ranchere, D., Figarella-Branger, D., Audry, G., Puget, S., Evans, D. G., . . . Delattre, O. (2011). Frequent hSNF5/INI1 Germline Mutations in Patients with Rhabdoid Tumor. Clinical Cancer Research. https://doi.org/10.1158/1078-0432.ccr-10-1795

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.